Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02671227
Other study ID # intrathecal Mg in gyne. lap.
Secondary ID
Status Completed
Phase Phase 2
First received January 24, 2016
Last updated January 26, 2017
Start date August 2016
Est. completion date January 2017

Study information

Verified date August 2016
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators aim to investigate the differences between intrathecal Bupivacaine + Mg sulfate in spinal anesthesia versus Bupivacaine on surgeon satisfaction and postoperative pain in gynecologic laparoscopic surgeries.


Description:

The investigators aim to investigate the differences between intrathecal Bupivacaine + Mg sulfate in spinal anesthesia versus Bupivacaine on surgeon satisfaction, patient satisfaction and postoperative pain in gynecologic laparoscopic surgeries.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date January 2017
Est. primary completion date January 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- female patient.

- more than 18 years.

- undergoing elective gynecologic laparoscopic surgeries.

Exclusion Criteria:

- allergy to local anesthesia.

- contraindication to spinal anesthesia.

- Significant cardiac, liver or renal dysfunction.

- Inability to informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
intrathecal Mg sulfate.
intrathecal Mg sulfate 50 mg.
intrathecal bupivacaine 15 mg.
intrathecal bupivacaine 15 mg.

Locations

Country Name City State
Egypt Asiut university hospital Asiut

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary surgeon satisfaction (scale from 1 to 10) . surgeon satisfaction (scale from 1 to 10) as 1 is worst and 10 is best. intraoperative (from beginning of the gynecologic laparoscopic procedure till the end of the procedure).
Secondary postoperative pain management (VAS score). Visual Analog Scale (VAS score). postoperative for 6 hours.
See also
  Status Clinical Trial Phase
Completed NCT03776838 - Impact of Nociceptive-Level (NOL) Intraoperative Guided Analgesia During Gynecological Laparoscopic Surgery Under General Anesthesia Phase 4
Completed NCT01512914 - Impact of Intraperitonael Nebulization of Local Anesthetic on Postoperative Pain Associated With Laparoscopic Surgery Phase 3